Pfizer Inc.

NYSE:PFE   12:03:43 PM EDT
-0.17 (-0.40%)
Products, Strategic Combinations, Regulatory

Exelixis Announces Clinical Trial Collaboration And Supply Agreement With Merck KGaA, Germany And Pfizer

Published: 03/18/2021 12:16 GMT
Pfizer Inc. (PFE) - Exelixis Announces Clinical Trial Collaboration and Supply Agreement With Merck Kgaa, Darmstadt, Germany and Pfizer to Evaluate Xl092 and Avelumab in Various Forms of Locally Advanced Or Metastatic Urothelial Carcinoma.
Exelixis Inc - New Expansion Cohorts to Be Added to Ongoing Stellar-001 Trial Following Dose-escalation Phase.
Exelixis Inc - Co is Sponsoring Stellar-001 Clinical Trial, and Merck Kgaa, and Pfizer Will Provide Avelumab for Use in Trial.